CHCHD3 Double Nickase Plasmid (h): sc-408682-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- CHCHD3 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- CHCHD3 Double Nickase Plasmid (h) and CHCHD3 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting CHCHD3. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CHCHD3 Double Nickase Plasmid (h) | sc-408682-NIC | 20 µg | $410.00 |
CHCHD3 encodes a mitochondrial inner membrane protein that functions as a core component of the MICOS complex, helping organize cristae architecture and maintain mitochondrial ultrastructure. By coordinating inner membrane junctions and interacting with factors involved in mitochondrial dynamics and protein import, CHCHD3 contributes to oxidative phosphorylation efficiency, bioenergetic homeostasis, and mitochondrial quality control. Perturbation of MICOS components, including CHCHD3, is linked to altered cristae remodeling, impaired respiration, and stress signaling pathways such as mitophagy and the integrated stress response. These processes are broadly relevant to studies of neurodegeneration, cardiometabolic dysfunction, and cancer cell metabolic reprogramming where mitochondrial structure–function relationships are disrupted.
CHCHD3 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the CHCHD3 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within CHCHD3. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt CHCHD3 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of CHCHD3-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.